Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study

Online download statistics by month:

Online download statistics by month: May 2019 to March 2024

	Abstract	Full	Pdf
May 2019	666	718	147
Jun 2019	561	645	35
Jul 2019	343	382	22
Aug 2019	586	612	42
Sep 2019	493	526	20
Oct 2019	170	168	16
Nov 2019	97	93	26
Dec 2019	248	250	50
Jan 2020	216	206	39
Feb 2020	124	120	25
Mar 2020	96	95	15
Apr 2020	78	76	20
May 2020	65	65	20
Jun 2020	76	74	26
Jul 2020	95	93	30
Aug 2020	47	43	12
Sep 2020	72	71	13
Oct 2020	93	87	40
Nov 2020	45	42	12
Dec 2020	83	70	11
Jan 2021	54	53	17
Feb 2021	30	29	13
Mar 2021	56	56	21
Apr 2021	26	27	13
May 2021	18	18	18
Jun 2021	25	23	14
Jul 2021	23	24	8
Aug 2021	23	18	9
Sep 2021	30	30	13
Oct 2021	39	36	22
Nov 2021	38	39	23
Dec 2021	48	46	13
Jan 2022	31	31	10
Feb 2022	26	27	12
Mar 2022	21	22	11
Apr 2022	26	25	7
May 2022	32	32	11
Jun 2022	36	41	18
Jul 2022	22	22	4
Aug 2022	41	41	21
Sep 2022	40	38	12
Oct 2022	36	35	7
Nov 2022	15	15	12
Dec 2022	20	20	11
Jan 2023	11	11	7
Feb 2023	34	34	11
Mar 2023	20	17	8
Apr 2023	16	15	14
May 2023	17	17	12
Jun 2023	14	15	7
Jul 2023	13	12	12
Aug 2023	25	24	15
Sep 2023	16	16	5
Oct 2023	14	13	2
Nov 2023	42	44	13
Dec 2023	26	26	8
Jan 2024	20	20	7
Feb 2024	13	12	10
Mar 2024	24	24	58
Total	5315	5484	1130